Literature DB >> 6847217

Treatment of pityriasis rosea with UV radiation.

K A Arndt, B S Paul, R S Stern, J A Parrish.   

Abstract

Twenty patients with symptomatic and extensive pityriasis rosea were treated with unilateral UV-B phototherapy in a bilateral comparison study. Five consecutive daily erythemogenic exposures resulted in substantially decreased pruritus and extent of disease greater than that on the untreated side in approximately 50% of the patients. Therapy seems to be most beneficial to patients receiving treatment within the first week of the eruption.

Entities:  

Mesh:

Year:  1983        PMID: 6847217

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Low-dose Ultraviolet A1 Phototherapy for Treating Pityriasis Rosea.

Authors:  Sang Hee Lim; Sang Min Kim; Byung Ho Oh; Jong Hyun Ko; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

2.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

3.  Narrowband UVB phototherapy in pityriasis rosea.

Authors:  Vijayeeta Jairath; Madan Mohan; Nidhi Jindal; Paritosh Gogna; Clarify Syrty; Priyadarshini Mookalamada Monnappa; Sarabjit Kaur; Manu Sehrawat
Journal:  Indian Dermatol Online J       Date:  2015 Sep-Oct

Review 4.  Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria.

Authors:  Antonio Chuh; Vijay Zawar; Michelle Law; Gabriel Sciallis
Journal:  Infect Dis Rep       Date:  2012-02-15

Review 5.  Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects.

Authors:  Khushbu Mahajan; Vineet Relhan; Aditi Kochhar Relhan; Vijay Kumar Garg
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.